Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years

Conditions: Healthy Population Interventions: Biological: Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine; Biological: Group A and C Meningococcal Polysaccharide Vaccine; Biological: Group ACYW135 Meningococcal Polysaccharide Vaccine Sponsors: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials